| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $400.02M | $310.20M | $249.43M | $174.36M | $36.48M |
| Cost of Revenue | $5.09M | $2.73M | $1.04M | $1.09M | $0.00 |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $274.87M | $222.15M | $163.54M | $101.92M | $100.25M |
| SG&A | $165.41M | $155.78M | $144.50M | $123.06M | $110.82M |
| Operating Income | -$45.35M | -$70.46M | -$59.65M | -$51.71M | -$174.59M |
| Interest Expense | $12.17M | $18.84M | $5.15M | $5.41M | $5.57M |
| Tax Expense | $16.41M | -$1.85M | -$5.60M | $11.66M | $150.00K |
| Net Income | -$35.51M | -$51.09M | -$55.29M | -$52.54M | -$180.03M |
| EPS (basic) | -0.7100 | -1.0200 | -1.1300 | -1.1500 | -4.2400 |
| EPS (diluted) | -0.7100 | -1.0200 | -1.1300 | -1.1500 | -4.2400 |
| Shares (diluted) | $50.35M | $49.99M | $48.89M | $45.71M | $42.49M |